Back to Articles
Safety9 min readFebruary 7, 2025
Can Ozempic Cause Depression?
Examining the potential link between semaglutide and depression. What the research shows and warning signs to watch for.
By Med Consumer Watch Team
Reports of depression, anxiety, and suicidal thoughts in people taking GLP-1 medications have gained attention. Regulatory agencies including the FDA and EMA are investigating. But what does the evidence actually show, and should you be concerned?
What We Know So Far
The current situation:
Regulatory investigations:
The FDA and European Medicines Agency (EMA) have been reviewing reports of suicidal thoughts and self-harm in patients taking GLP-1 medications.
No definitive causal link:
As of early 2025, no clear causal relationship has been established. The agencies continue to monitor.
Clinical trial data:
Large clinical trials of semaglutide did not show significantly increased depression rates compared to placebo. However, trials may not capture all real-world effects.
Reports continue:
Individual reports of mood changes persist, warranting ongoing attention.
Reports of potential side effects don't prove causation. They indicate a signal worth investigating.
Why the Connection Is Complex
Several factors complicate understanding this relationship:
Weight loss and mood:
Weight loss itself can affect mood—both positively and negatively. Distinguishing medication effects from weight loss effects is difficult.
Pre-existing conditions:
Depression and obesity commonly co-occur. People taking Ozempic may have higher baseline depression rates.
Brain effects:
GLP-1 receptors exist in the brain. Theoretically, GLP-1 medications could affect mood pathways, though this isn't proven.
Reporting bias:
People may be more likely to report mental health changes on a new medication, whether or not the medication caused them.
Warning Signs to Watch For
If you're taking Ozempic, monitor for:
- New or worsening depression
- Unusual sadness or hopelessness
- Loss of interest in activities you previously enjoyed
- Significant anxiety or panic attacks
- Thoughts of self-harm or suicide
- Major changes in sleep patterns
- Withdrawal from friends and family
- Difficulty functioning at work or home
If you experience suicidal thoughts, contact the 988 Suicide and Crisis Lifeline immediately by calling or texting 988.
Who May Be at Higher Risk
Consider extra monitoring if you have:
• History of depression or other mental health conditions
• History of suicidal thoughts or attempts
• Bipolar disorder
• Severe anxiety disorders
• Current mental health treatment
This doesn't mean you can't take Ozempic, but close monitoring is important.
What to Do If You're Concerned
Steps to take:
Before starting:
• Inform your provider of any mental health history
• Have a mental health care plan in place
• Know the warning signs
While taking:
• Monitor your mood
• Keep a mood journal if helpful
• Stay connected with mental health support
• Don't stop Ozempic abruptly without guidance
If you notice changes:
• Contact your provider
• Don't dismiss symptoms as "just in your head"
• Your provider may adjust dose or consider alternatives
The Bigger Picture
Context matters:
GLP-1 medications help millions:
The vast majority of people take these medications without mental health complications.
Obesity and depression:
Untreated obesity also affects mental health. The benefits of treatment should be weighed against potential risks.
Individual variation:
People respond differently to medications. What affects one person may not affect another.
Ongoing research:
Our understanding will improve as more data accumulates.
The Bottom Line
The potential link between Ozempic and depression remains under investigation. Current evidence doesn't confirm a causal relationship, but monitoring continues. If you have a history of depression or mental health concerns, discuss this with your provider before starting Ozempic. Monitor your mood while taking it, and report any concerning changes promptly. Don't let fear of potential mental health effects prevent you from pursuing weight loss treatment, but do take mental health monitoring seriously as part of your overall care.
Sources & References
- FDA Drug Safety Communication - GLP-1 Medications
- European Medicines Agency Safety Review
- New England Journal of Medicine - Semaglutide Clinical Trial Data
Medical Disclaimer
This article is for informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making decisions about your health or medications. Individual experiences may vary.